Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140010/S106

IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter

Medtronic, Inc. · Decision date Sep 24, 2026

MEDTECHLEDGER EXPLANATIONP140010/S106

What did the FDA decide?

The FDA record P140010/S106, dated 2026-09-24 with decision OK30, is a 30-day notice for a process change under the manufacturer, sterilizer, packager or supplier category. The stated scope is approval of a change to the in-process testing strategy and sample size for balloon burst testing, proximal weld tensile strength testing, and distal tip weld tensile testing of the IN.PACT DCB 018 catheter.

The applicant is Medtronic, Inc.; the product code is ONU and the device category is drug-eluting peripheral transluminal angioplasty catheter. The source statement identifies three distinct test areas, but it does not give the prior or revised sample sizes, the test methods, or any supporting performance results, and it does not establish safety or clinical effectiveness. The record does not describe the original PMA scope beyond this supplement relationship.

FDA approval order statement

approval for a change to the in-process testing strategy and sample size for balloon burst testing, proximal weld tensile strength testing, and distal tip weld tensile of the IN.PACT DCB 018 catheter
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 24, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140010/S106
Regulatory pathway
PMA supplement
Product code
ONU
Decision code
OK30
Decision date
Sep 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Drug-Eluting Peripheral Transluminal Angioplasty Catheter.

Product code
ONU
FDA device class
3

For the original device and its historical approval scope, see PMA P140010. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P140010 · Original PMA

    IN.PACT Admiral Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter and IN.PACT 018 Paclitax

  2. P140010/S106 received

    Application receipt date recorded by FDA.

  3. P140010/S106 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P140010. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140010

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3576 Unocal Pl., Santa Rosa, CA, 95403

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records